Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-065002
Filing Date
2021-12-13
Accepted
2021-12-13 16:55:04
Documents
50
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_bespoke.htm   iXBRL 10-K 983206
2 CERTIFICATION f10k2021ex31-1_bespoke.htm EX-31.1 10554
3 CERTIFICATION f10k2021ex32-1_bespoke.htm EX-32.1 3847
  Complete submission text file 0001213900-21-065002.txt   4257161

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20210831.xsd EX-101.SCH 46138
5 XBRL CALCULATION FILE bspk-20210831_cal.xml EX-101.CAL 24033
6 XBRL DEFINITION FILE bspk-20210831_def.xml EX-101.DEF 220646
7 XBRL LABEL FILE bspk-20210831_lab.xml EX-101.LAB 430831
8 XBRL PRESENTATION FILE bspk-20210831_pre.xml EX-101.PRE 230254
9 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_bespoke_htm.xml XML 328047
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52759 | Film No.: 211488651
SIC: 2834 Pharmaceutical Preparations